Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
-94.32%
Change (1 year)
Categories
P/S ratio for Acorda Therapeutics (ACOR)
P/S ratio as of June 2024 (TTM): 0.0071
According to Acorda Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00709839. At the end of 2023 the company had a P/S ratio of 0.1593.
P/S ratio history for Acorda Therapeutics from 2006 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.1593 | 1.24% |
| 2022 | 0.1574 | -24.13% |
| 2021 | 0.2074 | -19.15% |
| 2020 | 0.2566 | -49.27% |
| 2019 | 0.5057 | -67.73% |
| 2018 | 1.57 | -8.06% |
| 2017 | 1.70 | 2.16% |
| 2016 | 1.67 | -55.3% |
| 2015 | 3.73 | -12.43% |
| 2014 | 4.26 | 20.12% |
| 2013 | 3.55 | 9.7% |
| 2012 | 3.23 | -0.04% |
| 2011 | 3.24 | -41.51% |
| 2010 | 5.53 | -68.36% |
| 2009 | 17.5 | 8.11% |
| 2008 | 16.2 | 1.77% |
| 2007 | 15.9 | 15.99% |
| 2006 | 13.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | 8.25 | 116,179.33% | 🇺🇸 USA |
 Repligen
RGEN | 13.5 | 190,467.16% | 🇺🇸 USA |
 Affimed
AFMD | 10.6 | 148,611.19% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | 6.18 | 86,941.15% | 🇺🇸 USA |